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Reactions of the anticancer complex [(6-bip)Ru(en)Cl] (where bip is biphenyl and en is
ethylenediamine) with the tripeptide glutathione (-l-Glu-l-Cys-Gly; GSH), the abundant
intracellular thiol, in aqueous solution give rise to two ruthenium cluster complexes, which
could not be identified by electrospray mass spectrometry (ESI-MS) using a quadrupole mass
analyzer. Here we use Fourier transform ion cyclotron mass spectrometry (nanoLC-FT-ICR
MS) to identify the clusters separated by nanoscale liquid chromatography as the tetranuclear
complex [{(6-bip)Ru(GSO2)}4]
2 (2) and dinuclear complex [{(6-bip)Ru(GSO2)2}2]
8 (3) con-
taining glutathione sulfinate (GSO2) ligands. Use of
18OH2 showed that oxygen from water
can readily be incorporated into the oxidized glutathione ligands. These data illustrate the
power of high-resolution MS for identifying highly charged multinuclear complexes and
elucidating novel reaction pathways for metallodrugs, including ligand-based redox
reactions. (J Am Soc Mass Spectrom 2008, 19, 544–549) © 2008 American Society for Mass
SpectrometryComplexes of the second row, group 8 transi-tion-metal ruthenium are of medical interest.Two RuIII complexes are currently undergoing
clinical trials as anti-cancer agents, and RuII arene
complexes have shown promising activity in model
cancer systems [1]. Ruthenium has seven isotopes,
making the mass isotopic pattern of ion peaks of
ruthenium-containing compounds characteristic, yet
complicated [2–6]. In our previous work [2, 3, 7–9],
mass spectra acquired by electrospray ionization
(ESI-MS) equipped with a quadrupole mass analyzer
allowed unambiguous assignment of singly charged
ion peaks of mononuclear ruthenium arene com-
plexes as well as their adducts with amino acids,
peptides, and DNA. However, low-resolution ESI-Q
MS was unable to identify two multinuclear ruthe-
nium clusters, which arose from the reaction of the
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doi:10.1016/j.jasms.2007.12.002ruthenium arene anticancer complex [(6-bip)Ru-
(en)Cl] (where bip is biphenyl and en is ethylenedi-
amine) with the tripeptide glutathione (-l-Glu-l-
Cys-Gly; GSH) in aqueous solution [3]. Glutathione is
present in almost all cells at millimolar concentra-
tions and can detoxify some transition-metal ions.
In this work, we have applied nanoscale liquid
chromatography-Fourier transform ion cyclotron
mass spectrometry (nanoLC-FTICR MS) to identify
these clusters and 18OH2 derivatization to determine
whether oxygen from solvent becomes incorporated
into oxidized glutathione found in the products.
Experimental
Materials
[(6-bip)RuCl(en)][PF6] (1) was synthesized as de-
scribed elsewhere [10, 11]. Glutathione (GSH, reduced)
and disodium hydrogen phosphate were purchased from
Sigma (Dorset, UK), sodium dihydrogen phosphate
from Aldrich (Dorset, UK), trifluoroacetic acid (TFAH)
from Acros (Geel, Belgium) (Andover, MA) 18O-labeled
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18O) from Cambridge Isotope Laboratories
(Andover, MA).
Instrumentation
Positive-ion electrospray ionization mass spectra were
obtained with a Bruker APEX III FT-ICR mass spec-
trometer (Bruker Daltonics, Billerica, MA) equipped
with a 9.4 tesla actively shielded superconducting mag-
net (Magnex, UK). The instrument was modified in-
house by the replacement of the glass capillary with a
heated metal transfer capillary held at a temperature of
423 K and a potential of 50 V. Ions were accumulated in
an RF-only hexapole ion storage region for 2 s (1.2 
107 mbar), before being transferred into the “infinity”
cell (1.5  1011 mbar) using “sidekick” trapping. An
UltiMate 3000 series system (Dionex, UK) with nano-
flow splitter was coupled to the mass spectrometer using
an TriVersa NanoMate (Advion, Ithaca, NY) with an
electrospray potential of 1.7 kV. Mobile phase A: water
(for LC-MS application, Fisher Chemicals) containing
2% CH3CN and 0.1% TFAH; mobile phase B: CH3CN
(for LC-MS application, Fisher Chemicals, oughbor-
ough, UK) containing 20% water and 0.1% TFAH. The
sample was trapped and washed for 3 min at 30 L
min1 on a -Precolumn (300 m  5 mm, 5 m, 100
Å). The sample was eluted onto an analytical PepMap
100 column (75 m  15 cm, 3 m, 100 Å) held in a
column-oven at 303 K. The flow rate was 300 nL
min1, and gradient (Solvent B) was as follows: 0 to
30% until 23 min, 30 to 100% from 23 to 24 min, 100%
from 24 to 27 min, 100 to 0% from 27 to 29 min, and
reset to 0% until 30 min. All spectra were acquired
using XMass 7.02 (Bruker Daltonics) with 512 k data
points in the range 90–3000 m/z. Bruker Daltonics
Data Analysis software was used for analysis and
Figure 1. Chromatogram with TIC detection for the reaction of
[(6-bip)Ru(en)Cl] with GSH 2:20 mM in unbuffered solution
(pH  3) at 310 K for 48 h.post processing.Results and Discussion
In unbuffered solution (pH ca. 3) and at 310 K,
the ruthenium arene anticancer complex [(6-bip)
Ru(en)Cl] (1) reacted with 10 mol equivalent glutathi-
one (-l-Glu-l-Cys-Gly, GSH) to give two di-ruthenium
glutathione complexes as the main products (Figure S1,
which can be found in the electronic version of this
article), of which the di-ruthenium triply-S bridged
product centered at 13.99 min has been identified
previously by conventional LC-ESI MS and NMR [3].
The ESI-QMS showed that the fraction centered at 17.25
min contains a di-ruthenium glutathione sulfenate/
sulfinate complex (Figures S1 and S2). However, the
concentration of multinuclear ruthenium clusters in the
fraction eluted from 10.93 to 12.24 min was too low to
allow good ESI MS analysis (Figures S1 and S2). The
fraction centered at 17.25 min was also collected and
Figure 2. Mass spectra for fractions corresponding to LC peak 1
(retention times of 18.6, 18.2, and 17.9 min, Figure 1) for the
reaction of [(6-bip)Ru(en)Cl] and GSH 2:20 mM in water (pH 
3) at 310 K for 48 h.
546 WANG ET AL. J Am Soc Mass Spectrom 2008, 19, 544–549concentrated for ESI-Q MS and NMR experiments.
NMR results (Figure S3) show that only one set of
proton resonances is observed for the two biphenyl
ligands, suggesting that the two ruthenium centers in
this complex are equivalent. No resonances are ob-
served for the protons of the chelated ethylenediamin-
e(en) ligand, indicating that the en ligands have been
displaced from ruthenium by oxidized GSH ligands
(Figure S3). The NMR sample was diluted with 1:1
H2O/CH3CN and analyzed by ESI-Q MS with various
cone voltages in an attempt to obtain further structural
information. However, the low-resolution of the mass
spectra did not allow unambiguous identification of the
di-ruthenium product either, although several frag-
Figure 3. Mass spectra for fractions corresponding to LC peak 2
(retention times 23.3, 22.6, and 21.6, see Figure 1) from the reaction
of [(6-bip)Ru(en)Cl] and GSH 2:20 mM in water (pH  3) at 310
K for 48 h.mented ions observed with a cone voltage of 50 V(Figure S4) appeared to correspond to the release of
one and two sulfinate (GSO2) ligands from the parent
di-ruthenium complexes.
The di-ruthenium product was also detectable in the
reaction mixture of complex 1 with GSH under argon
and physiologically-relevant conditions (Ru:GSH 0.02:5
mM, in 22 mM NaCl, pH 7 at 310 K for 48 h; Figure S5).
Since the glutathione adduct may be involved in the
biological mechanism of action of this ruthenium arene
anticancer complex, ESI-FT-ICR MS experiments were
performed to identify the adducts.
To identify unambiguously the multinuclear ruthe-
nium glutathione product by MS, 5 L of a reaction
mixture of higher concentration of complex 1 with GSH
(2:20 mM) in unbuffered aqueous solution was incu-
bated at 310 K for 48 h and separated by a nanoscale
C18 reverse phase LC. The eluent was introduced to the
ESI-FT-ICR MS using the nanoMate. Two TIC peaks
were observed as shown in Figure 1. The partial mass
Figure 4. Isotopic models (dots, for which the values of x and y
correspond to the m/z value and intensity of the respective isotopic
ion peak) and mass spectra (lines) for fragment ions of arene
ruthenium sulfinate glutathione adducts: (a) {[(6-bip)Ru(GSO2)]4 





2) and (b) {[(6-
bip)Ru(GSO ) ]  3O  10H}2 ([C H O S N Ru0 ]2). Possible2 2 2 64 92 29 4 12 2
structures for the adducts are shown in Chart 2.
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shown in Figures 2 and 3, and the full scan spectra for
the fractions eluting at 17.2 and 22.6 min in Figures S6
and S7. For the fractions of the first LC peak, a series of
doubly charged ions is detected within the range m/z
1050–1110, with a mass difference between the neigh-
boring ion clusters of 16 Da, i.e., an O atom (Figure 2).
Corresponding to the doubly charged ion centered at
m/z 1083.6502 for the fraction eluting at 17.2 min, a
triply charged ion centered at m/z 722.4247 was ob-
served (Figure S6). Similarly, a series of doubly charged
ion peaks is detected within the range 900–930 for the
fractions of the second LC peak; the difference between
the neighboring ion clusters is also 16 Da, indicative
of the loss or gain of an O atom between them (Figure 3).
The full scan spectrum (Figure S7) for the fraction
eluting at 22.6 min shows a triply charged ion centered
at m/z 1217.1663 assignable to the dimer of the doubly
charged ion centered at m/z 913.1206.
FT-ICR MS has previously been applied to the un-
ambiguous determination of the oxidation state of iron
in a metalloprotein by matching experimental and the-
oretical isotopic abundance mass distribution [12]. The
isotopic simulations shown in Figure 4 suggest that
the two LC peaks contain mixtures of tetra- and
di-ruthenium sulfinate/sulfenate (GSO2H/GSOH see
Chart 1) glutathione complexes, respectively. The pos-
sible structures for the two main species are shown in
Chart 1. (a) GS(O)H (glutathione sulfenic acid) and (b) GS(O)2H
(glutathione sulfinic acid). As ligands for ruthenium, the sulfur
atom is deprotonated and at neutral pH then carries an overall
charge of 2 for both sulfenate (GSO) and sulfinate (GSO2)
groups.Chart 2.The isotopic simulations (Figure 4) suggest thatin the tetra-ruthenium adduct, two of the RuII ions from
the starting complex may be reduced to RuI, and in the
di-ruthenium complex, both of the RuII ions may be
reduced to Ru0. The biphenyl proton signals in the 1H
NMR spectrum shown in Figure S8 for the fraction
eluting from 10.90 to 12.50 min are too broad to observe,
appearing to support the possibility that the ruthenium
atoms in this cluster may be oxidized from RuII to RuI,
which is paramagnetic (although partial or complete
spin-pairing is possible). The IR spectra of both of the
adducts showed two bands at 855 and 920 cm1,
evidence for the formation of S–O single bonds in
S–O–H or S–O–M models. These data will stimulate
further investigations of the nature of the postulated
Ru–Ru, Ru–S, Ru–S–Ru, and Ru–S–O–Ru bonds, as well
as the oxidation state of Ru [e.g., by X-ray absorption
analysis].
The apparent stabilization of low oxidation states of
ruthenium by oxidized sulfur ligands is surprising but
may be aided by the formation of strong hydrogen
bonds involving sulfinato oxygens under the acidic
conditions used for chromatography and mass spec-
trometry (0.1% TFAH in the mobile phase) as has been
reported for NiII/NiI in the nickel sulfinate/sulfenate
complexes [13]. The presence of RuII and hydride li-
gands (shift of two electrons from Ru0 or 2RuI to H)
cannot readily be ruled out since RuII is known to form
stable hydride complexes. However no 1H NMR
Chart 2. Proposed structures of tetra- and di-ruthenium gluta-
thione sulfinate adducts. The exact nature of the bridges between
the ruthenium atoms in these clusters is unknown. In the presence
of TFAH (0.1%) in the mobile phase, the two carboxylate groups
and one SO group in the glutathione sulfinate ligands can be
protonated to give H GSO H ligands which carry charges2 2
of 1.
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chemical shifts) were detected. Also different species
may be stabilized in the gas phase after desolvation
than in solution.
The two fractions separated from the reaction mix-
ture of complex 1 with GSH (2:20 mM) were collected
using conventional HPLC and analyzed by ESI-FT-ICR
MS. A series of doubly- and triply charged ions was
observed and their m/z values and assignments are
listed in Table 1; the mass spectra are shown in Figures
S9 and S10. The results agree with the nanoLC-MS
measurements, confirming that the first LC peak,
shown in Figure 1, is a mixture of tetra-ruthenium
glutathione sulfinate/sulfenate complexes, and the sec-
ond, a mixture of di-ruthenium glutathione sulfinate/
sulfenate complexes.
Our previous work has shown that the mono-
ruthenium thiolate adduct formed from the reaction of
complex 1 with GSH under physiologically-relevant
conditions as described above is readily oxidized to the
sulfenate adduct in the presence of O2 [3]. However,
under argon, the same reaction gave rise to a small
amount of the di-ruthenium sulfinate adduct as shown
in Figure S5, implying that, under these conditions,
water may be involved as an oxygen donor during
formation of the oxidized thiolate ligands in the ruthe-
nium glutathione adducts, perhaps with accompanying
reduction of RuII. Next we used isotopic labeling to
test whether oxygen from solvent water can become
incorporated into the sulfenate/sulfinate ligands in the
Table 1. The mass-to-charge ratios of the most abundant
isotopomer of the ion fragments from the ruthenium sulfinate/
sulfenate glutathione adducts [{(6-bip)Ru(GSO2)}4]
2 (2) and
[{(6-bip)Ru(GSO2)2}2]
8 (3) detected by direct infusion
ESI-FT-ICR MS
Adducta m/z (obs) Ion
2 722.4247 {2  Glub  5O  5Hc}3
781.7766 {2  2O  5H}3
787.1078 {2  O  5H}3
792.4406 {2  5H}3
1083.6502 {2  4H  Glu  5O}2
1094.1453 {2  4H  Glu  4O}2
1103.6351 {2  4H  Glu  3O}2
1108.1169 {unknown}3
1173.1748 {2  4H  2O}2
1181.1743 {2  4H  O}2
1189.1709 {2  4H}2
3 556.7662 {3  Glu  Glyd  11H}3
565.7668 {3  Glu  3O  11H}3
609.1334 {3  3O  11H}3
665.0882 {3  Glu  Gly  GSO2  10H}
2
834.6312 {3  Glu  Gly  10H}2
848.1573 {3  Glu  3O  10H}2
913.1215 {3  3O  10H}2
aFor proposed structures of adducts see Chart 2 and for mass spectra
see Figures S9 and S10.
bIndicates loss of a Glu residue HO2CCH(NH2)CH2CH2CO (C5H8O3N).
cH indicates gain of a proton.
dIndicates loss of a Gly residue NHCH2CO2H (C2H4O2N).products.A reaction mixture of complex 1with GSH (2:20 mM)
in unbuffered 66.6% 18O-labeled water incubated at 310
K for 48 h was analyzed using the nanoLC-nanoESI-FT-
ICR MS method described above. Two peaks similar to
those shown in Figure 1 appeared in the TIC chromato-
gram (data not shown). The partial mass spectra of the
fractions eluting at 18.2 and 22.6 min are shown in
Figure 5, and the full scan spectra in Figures S11 and
S12. For the first fraction, a doubly charged ion centered
atm/z 1084.6487 and a triply charged ion centered atm/z
723.4261 (Figure 5 and Figure S11) were detected. Apart
from the doubly charged ion centered at m/z 915.1388
and the triply charged ion atm/z 1219.1722, a quadruply
charged ion centered at m/z 1371.6784 became detect-
able for the second fraction eluting at 22.6 min (Figure
5 and Figure S12), which appears to correspond to a
trimer of the doubly charged ion at m/z 915.1388. The
isotopic simulations (Figure 6) indicate that the two
fractions contain tetra- and di-ruthenium glutathione
sulfinate/sulfenate complexes, respectively, for which
the oxygen atoms in the sulfinate and sulfenate ligands
contain 18O and therefore arise from solvent water.
Conclusions
The glutathione adduct of the anticancer complex [(6-
bip)Ru(en)Cl] readily undergoes oxidation of coordi-
nated glutathione to give rise to two multinuclear
Figure 5. Mass spectra for fractions corresponding to LC peaks 1
and 2 from the reaction of [(6-bip)Ru(en)Cl] and GSH 2:20 mM
in 66.6% 18O-labeled water (pH  3) at 310 K for 48 h.
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uously identified as di-ruthenium and tetra-ruthenium
glutathione sulfinate complexes. The MS data suggest
that the initial RuII may have undergone reduction to
give RuI and Ru0 in these products. This possibility will
stimulate further work to elucidate the oxidation state
of ruthenium in these adducts and their coordination
geometries. With 18O-labeled water as solvent, FT-ICR
MS analysis indicated that oxygen atoms in sulfenate
and sulfinate products can arise from water, implying
that water can be involved in oxygen atom insertion
into S–O bonds in the sulfenate and sulfinate ligands.
Interestingly, the S–O bonds in cysteinyl sulfenate/
sulfinate ligands in enzymes are thought to be involved
in oxygen atom insertion into substrates and in biolog-
Figure 6. Isotopic model (dots, for which the values of x and y
correspond to the m/z and intensity of the respective isotopic ion
peak), and mass spectra (lines) for fragment ions of arene ruthe-
nium 18O-labeled glutathione sulfinate adducts. (a) {[(6-bip)
Ru(GS18O2)]4  Glu  5











2). Possible structures for the adducts
are shown in Chart 2.ical signaling processes [14–18]. This work illustratesthe power of FTMS coupled with nanoscale liquid
chromatography and isotopic labeling for elucidating
pathways for reactions of metallodrugs with intracellu-
lar biomolecules.
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